– UK, London – LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the election of Pete Wilver to its Board of Directors, effective immediately, bringing the Board with more than 30 years of business experience.
“Pete offers a wealth of strategic planning, business development and financial experience with large, multinational manufacturing companies that will bring additional acumen to our accomplished Board of Directors,” said Board Chair, William Kozy. “The Board welcomes Pete and looks forward to his engagement and contributions.”
About Peter Wilver
Peter Wilver retired from Thermo Fisher Scientific, Inc., a provider of laboratory products and services, in 2017 after serving as the EVP and CAO since 2015, as well as SVP and CFO from 2006 to 2015. He served as Thermo Electron’s VP and CFO from 2004-2006, having previously been VP, Financial Operations from 2000-2004. Throughout his career, he held financial leadership roles at Honeywell International, Grimes Aerospace Company, and General Electric Company. Other public company directorships in the past five years include Evoqua Water Technologies Corporation, Shoals Technology Group, CIRCOR International, Inc., and Tenet Healthcare Corporation.
About LivaNova
LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to providing hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 3,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals, and healthcare systems worldwide.
For more information: https://www.livanova.com/en-us
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.